Key result
Circulating levels of miR-29c, miR-424, and miR-451 measured 24 hours after radiotherapy for left-sided breast cancer were significantly correlated with left ventricular end-diastolic diameter at 3 years.
Why the study?
Patients receiving chest radiotherapy risk cardiac sequelae, but identifying those at highest risk of complications remains difficult.
Do short-term changes in circulating miRNA expression predict echocardiographic measures of cardiac dysfunction in women treated with radiotherapy for left-sided breast cancer?
Cohort (n=84)
Yes
Do short-term changes in circulating miRNA expression predict echocardiographic measures of cardiac dysfunction in women treated with radiotherapy for left-sided breast cancer?
Effect estimate: beta = 0.39 to 0.43
p-value: p < 0.05
Short-term changes in circulating miRNAs 24 hours after radiotherapy for left-sided breast cancer correlate with echocardiographic parameters of cardiac dysfunction at 3 years, suggesting their potential as early biomarkers for radiation-induced cardiotoxicity.
Circulating miRNA shifts post-RT were associated with later LV dilation; hypothesis-generating for early biomarkers, needing prospective validation before any clinical role.
Introduction: Patients treated with radiotherapy to the chest region are at risk of cardiac sequelae, however, identification of those with greatest risk of complications remains difficult. Here, we sought to determine whether short-term changes in circulating miRNA expression are related to measures of cardiac dysfunction in follow-up. Materials and methods: Two parallel patient cohorts were enrolled and followed up for 3 years after completion of RT to treat left-sided breast cancer. In the primary group (N=28) we used a a panel of 752 miRNAs to identify miRNAs associated with radiation and cardiac indices at follow up. In the second, independent cohort (N=56) we validated those candidate miRNAs with a targeted qPCR panel. In both cohorts. serum samples were collected before RT, 24h after the last dose and 1 month after RT; cardiac echocardiography was performed 2.5-3 year after RT. Results: Seven miRNAs in the primary group showed marked changes in serum miRNAs immediately after RT compared to baseline and associations with cardiopulmonary dose-volume histogram metrics. Among those miRNAs: miR-15b-5p, miR-22-3p, miR-424-5p and miR-451a were confirmed to show significant decrease of expression 24 hours post-RT in the validation cohort. Moreover, miR-29c, miR-451 and miR-424 were correlated with the end-diastolic diameter of the left ventricle, which was also confirmed in multivariable analysis adjusting for RT-associated factors. Conclusion: We identified a subset of circulating miRNAs predictive for cardiac function impairment in patients treated for left-sided breast cancer, although longer clinical observation could determine if these can be used to predict major clinical endpoints.
No takes yet. Share an insight, caveat, or question.
Chałubińska‐Fendler et al. (2023) conducted a cohort in Left-sided breast cancer (n=84). Radiotherapy vs. Baseline (pre-radiotherapy) was evaluated on Correlation of 24-hour post-radiotherapy circulating miRNA levels with left ventricle end-diastolic diameter at 3 years (beta = 0.39 to 0.43, p=p < 0.05). Circulating levels of miR-29c, miR-424, and miR-451 measured 24 hours after radiotherapy for left-sided breast cancer were significantly correlated with left ventricular end-diastolic diameter at 3 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: